Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 14287

1.

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.

Virdee PS, Moschandreas J, Gebski V, Love SB, Francis EA, Wasan HS, van Hazel G, Gibbs P, Sharma RA.

JMIR Res Protoc. 2017 Mar 28;6(3):e43. doi: 10.2196/resprot.7201.

PMID:
28351831
2.

Magnetic Resonance Imaging for Colorectal Cancer Metastasis to the Liver: Comparative Effectiveness Research for the Choice of Contrast Agents.

Seo N, Park MS, Han K, Lee KH, Park SH, Choi GH, Choi JY, Chung YE, Kim MJ.

Cancer Res Treat. 2017 Mar 14. doi: 10.4143/crt.2016.533. [Epub ahead of print]

3.

What is the Optimal Timing for Liver Surgery of Resectable Synchronous Liver Metastases from Colorectal Cancer?

Inoue Y, Imai Y, Osumi W, Shimizu T, Asakuma M, Hirokawa F, Hayashi M, Uchiyama K.

Am Surg. 2017 Jan 1;83(1):45-53.

PMID:
28234125
4.

The significance of transarterial chemoembolization combined with systemic chemotherapy for patients with KRAS wild-type unresectable metachronous colorectal carcinoma with liver metastases.

Yu Q, Zhang L, Fan S, Huang L, Wang X, Xindun C.

J Cancer Res Ther. 2016 Dec;12(Supplement):C205-C211. doi: 10.4103/0973-1482.200603.

5.

Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions : New advances in interventional oncology: state of the art.

De Cobelli F, Marra P, Ratti F, Ambrosi A, Colombo M, Damascelli A, Sallemi C, Gusmini S, Salvioni M, Diana P, Cipriani F, Venturini M, Aldrighetti L, Del Maschio A.

Med Oncol. 2017 Apr;34(4):49. doi: 10.1007/s12032-017-0903-8. Epub 2017 Feb 20.

PMID:
28220346
6.

Resection after preoperative chemotherapy versus synchronous liver resection of colorectal cancer liver metastases: A propensity score matching analysis.

Kim CW, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim TW, Kim JC.

Medicine (Baltimore). 2017 Feb;96(7):e6174. doi: 10.1097/MD.0000000000006174.

7.

Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: Is there a survival benefit?

Yoo TG, Cranshaw I, Broom R, Pandanaboyana S, Bartlett A.

Breast. 2017 Apr;32:162-172. doi: 10.1016/j.breast.2017.02.003. Epub 2017 Feb 11. Review.

PMID:
28193572
8.

Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry.

Jung J, Kang Y, Lee YJ, Kim E, Ahn B, Lee E, Kim JY, Lee JH, Lee Y, Kim CH, Chae YS.

J Pathol Transl Med. 2017 Mar;51(2):129-136. doi: 10.4132/jptm.2016.12.09. Epub 2017 Feb 14.

9.

Chemosaturation With Percutaneous Hepatic Perfusion in Unresectable Hepatic Metastases.

Glazer ES, Zager JS.

Cancer Control. 2017 Jan;24(1):96-101. Review.

10.
11.

Rectal Neuroendocrine Tumor G1 with a Solitary Hepatic Metastatic Lesion.

Nagata K, Tajiri K, Shimada S, Ando T, Hosokawa A, Matsui K, Imura J, Sugiyama T.

Intern Med. 2017;56(3):289-293. doi: 10.2169/internalmedicine.56.7523. Epub 2017 Feb 1.

12.

Liver abscess secondary to an endoscopic tattoo in the colon.

Aawsaj YM, Kelly S, Slater B.

Ann R Coll Surg Engl. 2017 Feb;99(2):e47-e48. doi: 10.1308/rcsann.2016.0304.

PMID:
28145777
13.

Totally laparoscopic anatomical liver resection for centrally located tumors: A single center experience.

Kim WJ, Kim KH, Shin MH, Yoon YI, Lee SG.

Medicine (Baltimore). 2017 Jan;96(4):e5560. doi: 10.1097/MD.0000000000005560.

14.

Angioedema in a patient with neuroendocrine tumour.

Bukhari S, Dirweesh A, Conaway H.

BMJ Case Rep. 2017 Jan 20;2017. pii: bcr2016218961. doi: 10.1136/bcr-2016-218961. No abstract available.

PMID:
28108442
15.

Effect of Substituting 50% Isovue for Sterile Water as the Delivery Medium for SIR-Spheres: Improved Dose Delivery and Decreased Incidence of Stasis.

Chao C, Stavropoulos SW, Mondschein JI, Dagli M, Sudheendra D, Nadolski G, Soulen MC.

Clin Nucl Med. 2017 Mar;42(3):176-179. doi: 10.1097/RLU.0000000000001532.

PMID:
28072623
16.

Temporal trends and regional variations in gastrointestinal cancer mortality in Peru, 2005-2014.

Hernández-Vásquez A, Bendezú-Quispe G, Azañedo D, Huarez B, Rodríguez-Lema B.

Rev Gastroenterol Peru. 2016 Oct-Dec;36(4):320-329.

PMID:
28062868
17.

Characterization of Conversion Chemotherapy for Secondary Surgical Resection in Colorectal Cancer Patients with Lung Metastases.

Nozawa H, Ishihara S, Kawai K, Hata K, Kiyomatsu T, Tanaka T, Nishikawa T, Otani K, Yasuda K, Sasaki K, Murono K, Nakajima J, Watanabe T.

Oncology. 2017;92(3):135-141. doi: 10.1159/000453335. Epub 2017 Jan 5.

PMID:
28052299
18.

Complications of liver resection in geriatric patients.

Dedinská I, Laca L, Miklušica J, Palkoci B, Skálová P, Lauková S, Osinová D, Strmeňová S, Janík J, Mokáň M.

Ann Hepatol. 2017 Jan-Feb;16(1):149-156. doi: 10.5604/16652681.1226934.

PMID:
28051804
19.

Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.

Fujiyoshi K, Yamamoto G, Takenoya T, Takahashi A, Arai Y, Yamada M, Kakuta M, Yamaguchi K, Akagi Y, Nishimura Y, Sakamoto H, Akagi K.

Anticancer Res. 2017 Jan;37(1):239-247.

PMID:
28011498
20.

Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes.

Moris D, Dimitroulis D, Vernadakis S, Papalampros A, Spartalis E, Petrou A, Pawlik TM, Felekouras E.

Anticancer Res. 2017 Jan;37(1):9-14. Review.

PMID:
28011468

Supplemental Content

Loading ...
Support Center